Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines
Key Highlights Judo Bio secures $100M in initial financing for kidney-targeted medicines. Series A co-led by Atlas Venture, TCG, and…
Browsing Tag
YK Bioventures
1 post